These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

ToolGen commences legal action in UK court over Vertex's genome editing therapy, CASGEVY ®Seeks to expand licensing of its proprietary CRISPR RNP technologySEOUL, South Korea, April 21, 2025 /PRNewswi ...

ToolGen, Inc. (KOSDAQ 199800), led by CEO Jong Sang Ryu and recognized as a global leader in genome editing technology, announced today that it has filed a patent infringement lawsuit in the United ...